Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. - sprookjes - yvandenbroek - TriplyDB

Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

http://www.wikidata.org/entity/Q37712974

about

Dosing antibiotics in neonates: review of the pharmacokinetic data.A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.

P2860

Q38649419-41000042-4AD8-49C6-A599-87BCFD6CE412 Q40985166-B360C6B4-62D6-4166-8182-41843FC322C5

P2860

Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

http://www.wikidata.org/entity/Q37712974

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Determination of vancomycin ph ...... nitial dosing recommendations.

@en

Determination of vancomycin ph ...... nitial dosing recommendations.

@nl

type

label

Determination of vancomycin ph ...... nitial dosing recommendations.

@en

Determination of vancomycin ph ...... nitial dosing recommendations.

@nl

prefLabel

Determination of vancomycin ph ...... nitial dosing recommendations.

@en

Determination of vancomycin ph ...... nitial dosing recommendations.

@nl

P1433

Q37712974-8E15A616-8D77-447D-9FB9-69DC5375D3E2

P1476

Q37712974-16009CE7-56BA-47A4-8308-1025AE1ADD5B

P2093

Q37712974-034405A5-2453-4EF5-B8F7-61A4C6FB696E

Q37712974-0E9059C8-56AE-41FC-B6A2-F14EC564F38D

Q37712974-11230833-0BB5-42D5-B3CE-93634A9BBB32

Q37712974-3F750071-2974-4BD7-8975-A2DCC3C09855

Q37712974-5BB60E69-4874-425F-B698-4D94D48857CC

Q37712974-821A880C-F4AF-40AD-A303-3C526DE3C5ED

Q37712974-8ADF9F04-2446-44F6-929A-E2C597189EB4

Q37712974-E52B2646-042D-45BC-8EF4-A5F96E031BEE

P2860

Q37712974-06F7FFCE-8EAD-40BD-96E4-CA5154D5BFA9

Q37712974-080AA03F-55BB-49DB-B5EF-B733E61A48FD

Q37712974-0B8A5180-A58A-490A-8D06-AA932BB27322

Q37712974-0E742F35-7514-4C9D-BD2B-97DD502D01A4

Q37712974-1F0DF051-C50D-45D2-9B79-D2EAC86D01D3

Q37712974-1FE50A34-51D3-4162-81A8-C3836216F5E5

Q37712974-21424655-A034-40FF-945A-3E989FFF7BFA

Q37712974-22B42180-018A-40B4-938C-7263D0C2913A

Q37712974-2552E66E-85B8-49F8-89CA-5DAF2AE73A33

Q37712974-4155A32A-4275-4718-A773-4CCD73610C68

P304

Q37712974-2DD502BB-E18C-45DC-A270-AFDF79646874

P31

Q37712974-0EE76DEB-BA27-45D6-B9CF-42A4C5A1A14C

P356

Q37712974-8A372F45-5120-4BC3-93AF-40A78F2B439E

P407

Q37712974-A528A0EF-6738-4060-BAE7-39AF62E63D3B

P433

Q37712974-4F102783-E1DE-4482-BA02-020640BF4A3D

P478

Q37712974-0F57490B-805E-4B7B-9A9C-01ABD5567A19

P577

Q37712974-A63FA06D-6602-4148-B0F3-EE04EF6066C2

P698

Q37712974-71A03730-0F3D-462F-9477-7B751EE50EA6

P932

Q37712974-40F6D797-86D3-444D-9A55-987350D0E82E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Determination of vancomycin ph ...... nitial dosing recommendations.

@en

P2093

Andrew Simor

http://www.w3.org/2001/XMLSchema#string

Dolores C Iaboni

http://www.w3.org/2001/XMLSchema#string

Julianne Kim

http://www.w3.org/2001/XMLSchema#string

Marion Elligsen

http://www.w3.org/2001/XMLSchema#string

Michael S Dunn

http://www.w3.org/2001/XMLSchema#string

Sandra A N Walker

http://www.w3.org/2001/XMLSchema#string

Scott E Walker

http://www.w3.org/2001/XMLSchema#string

Vanessa G Allen

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.

Pharmacokinetics in the newborn.

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.

Nosocomial infection in the NICU: a medical complication or unavoidable problem?

Vancomycin: pharmacokinetics and administration regimens in neonates.

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

P304

2830-2840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01718-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24614381

http://www.w3.org/2001/XMLSchema#string

P932

3993213

http://www.w3.org/2001/XMLSchema#string